Discussion
The other day, I discovered an old, folded road map in the glove compartment. It had faded colors and deep creases. After I spread it…
Myeloma is a rare blood cancer that begins in plasma cells, a type of white blood cell normally responsible for producing antibodies that help fight off infectious pathogens and other threats.
While myeloma treatment can drive the disease into remission, sometimes for long periods of time, the cancer will often come back after a few months or years, and additional treatments will be needed.
Discussion
The other day, I discovered an old, folded road map in the glove compartment. It had faded colors and deep creases. After I spread it…
Treatment with Tecvayli (teclistamab) was better than standard therapies at delaying disease progression and prolonging survival among previously-treated myeloma patients in a Phase…
Discussion
Here’s a ray of hope from the American Cancer Society (ACS): Its recently released annual Cancer Statistics report noted that the five-year relative cancer…
Discussion
Yesterday morning, I burned the toast. It wasn’t just a little, either. It was blackened to a crisp and set off the smoke alarm with…
Johnson & Johnson is now seeking regulatory approval in the European Union for Tecvayli (teclistamab) plus Darzalex Faspro (daratumumab and hyaluronidase-fihj) for…
Discussion
We’re nearly two weeks into the new year and I’m wondering, how are your resolutions going? If your answer is, “Not so well,” take heart…
Don't have an account?
|
Already have an account?
Create your account by filling in the information below:
By creating an account, you are agreeing to the Privacy Policy and Terms of Service.